This compound is a protected nucleoside derivative used as an intermediate in the synthesis of oligonucleotides. Its structure features a thymidine base with a benzamide modification and a dimethoxytrityl protecting group, which are typical for solid-phase DNA/RNA synthesis.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 104579-03-5
5'-O-Dimethoxytrityl-N-benzoyl-desoxycytidine
pharmaceutical intermediate
N4-Acetyl-2'-deoxycytidine
pharmaceutical intermediate
2-Hydroxy-3-methoxy-3,3-diphenylpropanoic Acid-d3 Methyl Ester
pharmaceutical intermediate
2,6-Diamino-4,5,6,7-tetrahydrobenzothiazole
pharmaceutical intermediate
6-Acetamido-2-amino-4,5,6,7-tetrahydrobenzothiazole
pharmaceutical intermediate
4-Phthalimidocyclohexanone
pharmaceutical intermediate
N-Benzoyl-2'-O-methoxyethyl-5-O-dimethoxytrityl-5-methylcytidine
pharmaceutical intermediate
N-Benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-deoxy-5-methyl-cytidine 3'-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite]
pharmaceutical intermediate
N-[1-[(2R,4S,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-hydroxyoxolan-2-yl]-5-methyl-2-oxopyrimidin-4-yl]benzamide
YWHPQMVQHSPNRU-LBFZIJHGSA-N
CC1=CN(C(=O)N=C1NC(=O)C2=CC=CC=C2)[C@H]3C[C@@H]([C@H](O3)COC(C4=CC=CC=C4)(C5=CC=C(C=C5)OC)C6=CC=C(C=C6)OC)O